Drug Database
Back to search

Poland· PL-100167607

Stocrin

A efavirenz product containing efavirenzum, registered in Poland by Merck Sharp & Dohme B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC J05AG03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedStocrinATCJ05AG03REGISTER NO.PL-100167607PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about efavirenzumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Efavirenz is registered in 16 of 19 countries.

Countries holding a registration under ATC J05AG03 (efavirenz), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search efavirenz products by name

Efavirenz · ATC J05AG03

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of efavirenz costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), the median price runs from $9.90 in Switzerland to $66.82 in France — a ×6.7 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Efavirenz · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • FR France$66.82
  • CH Switzerland$9.90
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Efavirenzum
Manufacturer
Merck Sharp & Dohme B.V.
Country
Poland (PL)
ATC code
J05AG03
ATC class
Efavirenz
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990042197

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

486 interactions on record for efavirenz.

Graded by severity as the source publishes them — 137 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check efavirenz against other medicinesHow interaction checks work

Efavirenz · interactions on record

486 records

  • 137 severe
  • 278 moderate
  • 8 minor
  • 48 info

Most severe, free to view

  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe

15 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Efavirenz in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All efavirenz products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Efavirenz Sandoz
  • Belgium · Efavirenz Viatris
  • Cyprus · Efavirenz Aurobindo
  • Germany · Efavirenz Aurobindo
  • Denmark · Efavirenz "sandoz", Efavirenz Aurobindo
  • Estonia · Efavirenz Sandoz
  • Spain · Efavirenz Aurovitas
  • Finland · Efavirenz Aurobindo, Efavirenz Sandoz
  • France · Efavirenz Arrow, Efavirenz Sandoz
  • United Kingdom (Northern Ireland) · Efavirenz Accord, Efavirenz Amarox
  • Iceland · Efavirenz Teva
  • Liechtenstein · Efavirenz Teva
  • Netherlands · Efavirenz Accord, Efavirenz Aurobindo
  • Norway · Efavirenz Sandoz, Efavirenz Teva
  • Portugal · Efavirenz Aurobindo, Efavirenz Farmoz
  • Sweden · Efavirenz Aurobindo, Efavirenz Medical Valley

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1f2558fe-490c-4818-9dc6-38112e2e5638
GET /v1/drugs/1f2558fe-490c-4818-9dc6-38112e2e5638?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "05909990042197 ¦ Rpz ¦ EU/1/99/111/010 ¦ 35433\n1 butelka 30 tabl.",
  "substance": "Efavirenzum 50 mg",
  "common_name": "Efavirenzum",
  "pl_product_id": "100167607",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about efavirenz.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console